Cargando…

Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials

Purpose: A novel once-daily divalproex-extended release (ER) dose formulation has been developed; this formulation prolongs the therapeutic serum levels of the drug, compared with the twice-daily conventional divalproex-delayed release (DR) formulation. This study aimed to systematically examine and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chen Qi, Li, Hong Yan, Wan, Yong, Bai, Xue Yang, Gan, Lu, Wang, Juan, Sun, Hong Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037144/ https://www.ncbi.nlm.nih.gov/pubmed/35479307 http://dx.doi.org/10.3389/fphar.2022.811017

Ejemplares similares

Efficacy, safety, and retention rate of extended-release divalproex versus conventional delayed-release divalproex: A protocol for systematic review and meta-analysis
por: Zhang, Chen Qi, et al.
Publicado: (2021)

Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
por: Stoner, Steven C, et al.
Publicado: (2007)

Release property study on the novel divalproex sodium enteric-coated capsules
por: Yang, Shuoye, et al.
Publicado: (2016)

Divalproex sodium in severe anaemia: A case report
por: Gupta, Maneesh
Publicado: (2007)

Suicidality and divalproex sodium: analysis of controlled studies in multiple indications
por: Redden, Laura, et al.
Publicado: (2011)

Divalproex sodium: A potential therapy for scleroderma digital ulcers
por: Urban, Jennifer R., et al.
Publicado: (2015)

Immediate switching from a chrono to an extended-release formulation of divalproex sodium: A two-part study in patients with controlled epilepsy
por: Shukla, Rakesh, et al.
Publicado: (2008)

Rifampin – Risperidone and Divalproex Drug-drug Interaction: A Case Report
por: Park, Seo-Young, et al.
Publicado: (2023)

Acute hyponatremia with accompanying hyperammonemia secondary to divalproex sodium: A case report
por: Maister, Ashley J., et al.
Publicado: (2018)

Rifampin-divalproex drug-drug interaction in an adult patient: A case report
por: Doran, Christine, et al.
Publicado: (2021)

Pleural Effusion Associated With Divalproex Sodium: A Case Report and Literature Review
por: Chen, Pei, et al.
Publicado: (2023)

Drug–drug interaction study of ciprofol and sodium divalproex: Pharmacokinetics, pharmacodynamics, and safety in healthy Chinese subjects
por: Yang, Dandan, et al.
Publicado: (2023)

Divalproex sodium leading to sustained significant improvement in tardive dyskinesia in a patient with bipolar disorder
por: Pattanayak, Raman Deep, et al.
Publicado: (2016)

Non-aromatic Anticonvulsant (Divalproex Sodium)-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome
por: Dutta, Priyata, et al.
Publicado: (2021)

A pilot trial of quetiapine, lithium, or placebo added to divalproex sodium for hypomanic or manic episodes in ambulatory adults with bipolar I disorder
por: Cosgrove, Victoria E., et al.
Publicado: (2022)

Safety of liposome extended-release bupivacaine for postoperative pain control
por: Portillo, Juan, et al.
Publicado: (2014)

Symptoms predicting remission after divalproex augmentation with olanzapine in partially nonresponsive patients experiencing mixed bipolar I episode: a post-hoc analysis of a randomized controlled study
por: Houston, John P, et al.
Publicado: (2010)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

The Effect of Rotigotine Extended-Release Microspheres Alone or With Celecoxib on the Inflammatory Pain
por: Li, Keke, et al.
Publicado: (2020)

Pharmacokinetics of immediate release, extended release, and gastric retentive gabapentin formulations in healthy adults
por: Swearingen, Dennis, et al.
Publicado: (2018)

The Effect of Once-Daily Gabapentin Extended Release Formulation in Patients With Postamputation Pain
por: Knezevic, Nebojsa Nick, et al.
Publicado: (2019)

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder
por: Pliszka, Steven R., et al.
Publicado: (2017)

Pharmacokinetic comparison of sitagliptin and metformin HCl extended-release tablets versus JANUMET(®) XR in healthy volunteers under fasting and fed conditions
por: Que, Linling, et al.
Publicado: (2023)

Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats
por: Yutong, Mao, et al.
Publicado: (2023)

Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey
por: Liu, Chang, et al.
Publicado: (2021)

Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson’s disease
por: Hauser, Robert A., et al.
Publicado: (2022)

Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
por: Roesch, Benno, et al.
Publicado: (2013)

The effect of tacrolimus conversion from immediate- to extended-release formulation on renal function in renal transplant patients: a meta-analysis
por: Chao, Sheng, et al.
Publicado: (2023)

Population Pharmacokinetics of Viloxazine Extended‐Release Capsules in Pediatric Subjects With Attention Deficit/Hyperactivity Disorder
por: Nasser, Azmi, et al.
Publicado: (2021)

Piperine Suppresses Pyroptosis and Interleukin-1β Release upon ATP Triggering and Bacterial Infection
por: Liang, Yi-Dan, et al.
Publicado: (2016)

Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release
por: Benedek, Irma H, et al.
Publicado: (2011)

Estimation of the In Vivo Release of Amiodarone From the Pharmacokinetics of Its Active Metabolite and Correlation With Its In Vitro Release
por: Shleghm, Maytham Razaq, et al.
Publicado: (2021)

Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations
por: Incledon, Bev, et al.
Publicado: (2022)

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women
por: Xu, Yi, et al.
Publicado: (2022)

Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke(®) and Glucophage(®)-XR) in healthy Chinese volunteers: a randomized phase I clinical trial
por: Sun, Ming-Li, et al.
Publicado: (2022)

An extended release for surfactant
por: Wells, William A.
Publicado: (2001)

Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design
por: Khatun, Sabera, et al.
Publicado: (2014)

TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder
por: Dudek, Dominika, et al.
Publicado: (2023)

Retraction: Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design
Publicado: (2016)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s58ljdngqar9svc62tifd1tt5a